orthobiologics
-
Biologics
Xtant Medical Highlights Growing Product Portfolio at NASS 2023
BELGRADE, Mont., Oct. 12, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
Orthobiologics Market to Surpass US$ 10,300.6 Million by 2030, Says Coherent Market Insights (CMI)
Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global orthobiologics market is estimated to be valued at US$ 6,515.2 in 2022 and is…
Read More » -
Biologics
Orthobiologics market size to increase by USD 2,638.44 million: North America will account for 41% of market growth – Technavio
NEW YORK, Jan. 24, 2023 /PRNewswire/ — The orthobiologics market by product and geography – forecast and analysis 2023-2027 report has been published by…
Read More » -
Biologics
Global Orthobiologics Market valued at $5.4 billion in 2021, is expected to witness a decent growth rate of 7% in the next 5 years
Medi-Tech Insights: Growing cases of sports injuries and road accidents, increasing geriatric and obese population globally, rising number of people…
Read More » -
Financial
Global Orthobiologics Market to Generate Revenue of $6.91 billion by 2028 – SkyQuest Technology
Global orthobiologics market was valued at US$ 5.01 billion in 2021, and it is expected to reach a value of…
Read More » -
Biologics
Orthobiologics Market | Exclusive Report on the Latest Revenue and Future Scope – MDC Research
North America will continue to dominate the global market in the forecast period owing to factors such as growing need…
Read More » -
Biologics
Kuros Biosciences Further Strengthens Orthobiologics Patent Portfolio
SCHLIEREN (ZURICH), Switzerland, July 22, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences (SIX: KURN) today announced that its Dutch subsidiary, Kuros…
Read More » -
Biologics
Orthobiologics Market for Bone Repair & Regeneration, 2018-2024 – Dominated by Medtronic, MTF Biologics, NuVasive, and Orthofix
DUBLIN, April 15, 2020 /PRNewswire/ — The “Orthobiologics for Bone Repair and Regeneration” report has been added to ResearchAndMarkets.com offering. Over the forecast period…
Read More » -
Biologics
Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio
HILLSBORO, OREGON (PRWEB) MARCH 13, 2020 Acumed LLC today announced that it has entered into an agreement with Vivorte Inc. to…
Read More » -
Biologics
Orthobiologics Market Worth 6.06 Billion USD by 2022
PUNE, India, September 27, 2017 /PRNewswire/ — According to a new market research report “Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP,…
Read More »